Q32 BIO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.8 USD | +1.98% |
|
+4.00% | +144.88% |
| 11/04 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
| 03/04 | Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q32 BIO INC. | Bio Therapeutic Drugs | +1.98% | +4.00% | - | - | - | 314M |  |  | |
- Stock Market
- Equities
- QTTB Stock
- Charts Q32 Bio Inc.
- Relative Strength Chart